Diet and Depression
A growing body of evidence suggests that a diet that promotes heart health also supports brain health.
Benzodiazepines and Dementia
Benzodiazepines probably do not contribute to the risk of irreversible cognitive decline, but they should be used sparingly and cautiously in older patients.
Antidepressants, Heart Disease, and Mortality
Depression can present life-threatening risks to patients with heart conditions, but antidepressant medications can be both protective and potentially hazardous in this population.
A High and Increasing Trajectory of Depressive Symptoms Is Associated with Increased Risk of Dementia; Androgen Deprivation Therapy for Prostate Cancer is Linked to Depression
Antidepressant Adherence Lowers Mortality Risk
Poor antidepressant adherence can lead to a greater risk of relapse, recurrence, and chronic symptoms, and new evidence suggests it also increases the risk of all-cause mortality.
About the BTP Newsletter
Our subscribers say BTP is…
"Very relevant, practical, and thought-provoking."
"About the only thing left without drug ads...objective and balanced."
"Succinct, readable, clear, timely and relevant!"
"Well written and scientifically sound."
Originating at the Massachusetts General Hospital and Harvard Medical School, Biological Therapies in Psychiatry has been a trusted resource for physicians for over 30 years. Described as "influential" by the Atlantic Monthly, this concise, four-page, monthly newsletter provides up-to-date information about the rapidly expanding field of psychotropic medications and other biological treatments for mental disorders.
From his perspective as an editor, teacher, investigator, and clinician, Alan J. Gelenberg, M.D., reviews the widespread literatures of science and clinical practice. Dr. Gelenberg distills the material most relevant for a busy practitioner and presents it each month with a balance of scientific curiosity, healthy skepticism, and clinical experience.
Dr. Gelenberg is Professor and Interim Chair of Psychiatry at Penn State, Hershey. Since 1987, Dr. Gelenberg has been Editor-in-Chief of the Journal of Clinical Psychiatry, and he recently chaired the workgroup that revised the American Psychiatric Association's major depressive disorder guidelines. Dr. Gelenberg has been on the faculty of Harvard Medical School, MIT, and the University of Arizona and has written numerous scientific articles and book chapters on mood disorders, depression, and schizophrenia. He is listed in the Best Doctors in America and America's Top Doctors and received the 1997 Exemplary Psychiatrist Award of the National Alliance for the Mentally Ill.
We offer both print and online subscriptions. Our web site provides subscribers with 24-hour access to archives as well as current issues. In addition, Continuing Medical Education credit is available for reading BTP. You can earn up to 12.0 hours in category 1 credit by answering questions in the December issue about topics covered during the year.